OptiNose Inc
NASDAQ:OPTN
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
OptiNose Inc
Total Liabilities & Equity
OptiNose Inc
Total Liabilities & Equity Peer Comparison
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
OptiNose Inc
NASDAQ:OPTN
|
Total Liabilities & Equity
$83.7m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Liabilities & Equity
$172B
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Liabilities & Equity
$99B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
23%
|
CAGR 10-Years
11%
|
|
Pfizer Inc
NYSE:PFE
|
Total Liabilities & Equity
$221.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
Merck & Co Inc
NYSE:MRK
|
Total Liabilities & Equity
$105.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
0%
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Liabilities & Equity
$63.9B
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
6%
|
See Also
What is OptiNose Inc's Total Liabilities & Equity?
Total Liabilities & Equity
83.7m
USD
Based on the financial report for Mar 31, 2024, OptiNose Inc's Total Liabilities & Equity amounts to 83.7m USD.
What is OptiNose Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
-15%
Over the last year, the Total Liabilities & Equity growth was -27%. The average annual Total Liabilities & Equity growth rates for OptiNose Inc have been -19% over the past three years , -15% over the past five years .